192 related articles for article (PubMed ID: 15008985)
1. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.
Schmidt E; Wehr B; Tabengwa EM; Reimer S; Bröcker EB; Zillikens D
Clin Exp Immunol; 2004 Mar; 135(3):497-504. PubMed ID: 15008985
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
[TBL] [Abstract][Full Text] [Related]
3. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone.
Schmidt E; Reimer S; Kruse N; Bröcker EB; Zillikens D
Clin Exp Immunol; 2001 Apr; 124(1):157-62. PubMed ID: 11359455
[TBL] [Abstract][Full Text] [Related]
4. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
[TBL] [Abstract][Full Text] [Related]
6. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.
Iwata H; Kamio N; Aoyama Y; Yamamoto Y; Hirako Y; Owaribe K; Kitajima Y
J Invest Dermatol; 2009 Apr; 129(4):919-26. PubMed ID: 19177144
[TBL] [Abstract][Full Text] [Related]
7. Internalization of the 180 kDa bullous pemphigoid antigen as immune complexes in basal keratinocytes: an important early event in blister formation in bullous pemphigoid.
Kitajima Y; Nojiri M; Yamada T; Hirako Y; Owaribe K
Br J Dermatol; 1998 Jan; 138(1):71-6. PubMed ID: 9536225
[TBL] [Abstract][Full Text] [Related]
8. Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes: functionally relevant modification by calcium.
Schmidt E; Wehr B; Wolf K; Sitaru C; Bröcker EB; Zillikens D
Arch Dermatol Res; 2006 Nov; 298(6):283-90. PubMed ID: 16906396
[TBL] [Abstract][Full Text] [Related]
9. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.
Ståhle-Bäckdahl M; Inoue M; Guidice GJ; Parks WC
J Clin Invest; 1994 May; 93(5):2022-30. PubMed ID: 8182134
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
11. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
[TBL] [Abstract][Full Text] [Related]
12. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
13. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
Schaefer BM; Jaeger C; Drepper E; Kramer MD
Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
[TBL] [Abstract][Full Text] [Related]
15. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
16. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
Borradori L; Chavanas S; Schaapveld RQ; Gagnoux-Palacios L; Calafat J; Meneguzzi G; Sonnenberg A
Exp Cell Res; 1998 Mar; 239(2):463-76. PubMed ID: 9521865
[TBL] [Abstract][Full Text] [Related]
17. Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid.
Sato M; Shimizu H; Ishiko A; Masunaga T; Akiyama M; Hashimoto T; Kitajima Y; Nishikawa T
Br J Dermatol; 1998 Jun; 138(6):965-71. PubMed ID: 9747356
[TBL] [Abstract][Full Text] [Related]
18. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
20. A critical role for neutrophil elastase in experimental bullous pemphigoid.
Liu Z; Shapiro SD; Zhou X; Twining SS; Senior RM; Giudice GJ; Fairley JA; Diaz LA
J Clin Invest; 2000 Jan; 105(1):113-23. PubMed ID: 10619867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
